A study of 58 KS IRIS patients in SSA and the UK found that KS associated mortality was 3.3 fold higher in SSA compared to the UK and was predicted by KS-IRIS, lack of chemotherapy, pre-ART CD4 <200 cells/μL, and detectable baseline KSHV DNA. Here, CD4 is linked to Kaposi's sarcoma.